Take Your Trading To The Next Level. Get Started Here!
+1 (949) 514 8188
The FDA plans to call a last-minute meeting of its outside advisors to further review the Eli Lilly Alzheimer’s treatment’s safety and efficacy.
Eli Lilly says FDA delays approval of Alzheimer’s drug in surprise move
The FDA plans to call a last-minute meeting of its outside advisors to further review the Eli Lilly Alzheimer’s treatment’s safety and efficacy.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender